Prognosis
Brazil Unveils Its Own Covid-19 Shot With Plans for July Rollout
- Vaccine developed by Butantan, region’s largest manufacturer
- Inoculation could be single dose, help low income countries
This article is for subscribers only.
Brazil’s Butantan Institute has developed its own Covid-19 vaccine, which it plans to roll out in the coming months and offer to low income countries to help fight the pandemic.
Sao Paulo-based Butantan, which has partnered with China’s Sinovac Biotech Ltd. to produce the CoronaVac shot, will begin trials for its own vaccine -- dubbed the ButanVac -- with plans to have supplies ready by July, the institute’s director Dimas Covas said at a press conference on Friday.
Have a confidential tip for our reporters? Get in Touch
Before it’s here, it’s on the Bloomberg Terminal
LEARN MORE
Up Next
Brazil Unveils Its Own Covid-19 Shot With Plans for July Rollout